NASDAQ: SNYRSynergy Chc Corp Stock
$5.76-0.34 (-5.57%)
Updated Nov 29, 2024
SNYR Price
$5.76
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$5.50
52 Week High
$10.00
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.43
Operating Cash Flow
N/A
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SNYR's potential to beat the market
- SNYR doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Distribution
Industry Rating
A
SNYR
RankedUnranked of 7
RankedUnranked of 7
Be the first to know about important SNYR news, forecast changes, insider trades & much more!
SNYR News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SNYR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SNYR's short-term liabilities ($14.71M) exceed its short-term assets ($10.87M)
Short-term Liabilities Financials
SNYR's long-term liabilities ($22.39M) exceed its short-term assets ($10.87M)
Long-term Liabilities Financials
SNYR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more SNYR due diligence checks available for Premium users.
Valuation
SNYR's financial health
Profit margin
Revenue
$8.0M
Net Income
$655.2k
Profit Margin
8.2%
Assets to liabilities
Assets
$11.2M
Liabilities
$37.1M
Debt to equity
-1.43
SNYR's short-term liabilities ($14.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNYR's long-term liabilities ($22.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNYR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SNYR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$282.0k
Investing
$0.0
Financing
-$597.2k
Synergy Chc Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.